8-K
Current Report
Spyre Therapeutics, Inc. Filed Acc 0001564590-21-032183
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading agle-8k_20210608.htm…